Ignite Creation Date:
2025-12-24 @ 10:42 PM
Ignite Modification Date:
2025-12-25 @ 8:12 PM
Study NCT ID:
NCT00004935
Status:
TERMINATED
Last Update Posted:
2023-04-18
First Post:
2000-03-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2
Sponsor:
Swiss Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1999-08-30
Start Date Type:
ACTUAL
Primary Completion Date:
2014-11-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2000-03-07
First Submit QC Date:
None
Study First Post Date:
2003-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-12
Last Update Post Date:
2023-04-18
Last Update Post Date Type:
ACTUAL